Volition announce collaboration agreement VolitionRX Small (VNRX.

Related StoriesCrucial switch in single DNA base predisposes children to intense type of cancerSausages With Antioxidants From Berries TO AVOID CancerStudy shows uncommon HER2 missense mutations usually do not spread breasts cancer on the ownCameron Reynolds, CEO of Volition, commented: We think that the data from the effective validation of thousands of well-annotated samples would be sufficient for all of us to pursue our goal of applying for CE Mark regulatory authorization in Europe in 2012, and would type a considerable basis for our applications for FDA authorization thereafter.If anything, the amounts in our research are an underestimate of what might be seen at less well-resourced institutions, that was somewhat surprising to us, Bona added. The findings were published Sept. 23 in the journal Pediatric Blood & Tumor. Recent research shows that young cancer individuals in low-income families are less inclined to take chemotherapy drugs as approved and also have lower survival rates, the scholarly study authors said. The researchers intend to conduct an additional study to determine if what they call home material hardship has the same influence on childhood cancer patients as low-income status.